株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ヒト胚性幹細胞の世界市場:用途別、地域別の市場規模とCOVID-19の影響を踏まえた予測:2020年~2026年

Global Human Embryonic Stem Cells Market Size study with COVID-19 Impact, by Application, and Regional Forecasts 2020-2026

発行 Bizwit Research & Consulting LLP 商品コード 935958
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.69円で換算しております。
ヒト胚性幹細胞の世界市場:用途別、地域別の市場規模とCOVID-19の影響を踏まえた予測:2020年~2026年 Global Human Embryonic Stem Cells Market Size study with COVID-19 Impact, by Application, and Regional Forecasts 2020-2026
出版日: 2020年05月01日 ページ情報: 英文
概要

当レポートは、新型コロナウイルス感染症(COVID-19)パンデミックの影響を踏まえつつ世界のヒト胚性幹細胞市場を調査したもので、市場の力学、業界の分析、用途別、地域別の分析、競合情勢と企業プロファイルなどの情報を提供しています。

第1章 エグゼクティブサマリー

第2章 市場の定義と範囲

第3章 市場の力学

  • 影響の分析(2018年~2026年)
    • 市場成長要因
    • 市場の課題
    • 市場機会

第4章 業界の分析

  • ポーターのファイブフォースモデル
    • サプライヤーの交渉力
    • バイヤーの交渉力
    • 新規参入勢力の脅威
    • 代替品の脅威
    • 企業間の競争
    • ポーターのファイブフォースモデルへの未来的なアプローチ
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの提言と結論

第5章 用途別の市場分析

  • 市場のスナップショット
  • 市場の実績と成長性の分析
  • 市場の予測
  • サブセグメント分析
    • 再生医療
    • 幹細胞の生物学研究
    • ヒト組織工学
    • 毒性試験

第6章 地域市場の分析

  • 各地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他

第7章 競合情報

  • 主な市場戦略
  • 企業プロファイル
    • Astellas Pharma Inc/ Ocata Therapeutics
    • Stemcell Technologies Inc.
    • Biotime, Inc. / Cell Cure Neurosciences LTD
    • Thermo Fisher Scientific, Inc.
    • CellGenix GmbH
    • ESI BIO
    • PromoCell GmbH
    • Lonza Group AG
    • Kite Pharma
    • Cynata Therapeutics Ltd

第8章 調査プロセス

図表

List of Tables

  • TABLE 1. List of secondary sources, used in the study of global Human Embryonic Stem Cells market
  • TABLE 2. List of primary sources, used in the study of global Human Embryonic Stem Cells market
  • TABLE 3. Global Human Embryonic Stem Cells market, report scope
  • TABLE 4. Years considered for the study
  • TABLE 5. Exchange rates considered
  • TABLE 6. Global Human Embryonic Stem Cells market estimates & forecasts by region 2016-2026 (USD Billion)
  • TABLE 7. Global Human Embryonic Stem Cells market estimates & forecasts by Application 2016-2026 (USD Billion)
  • TABLE 8. Global Human Embryonic Stem Cells market by segment, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 9. Global Human Embryonic Stem Cells market by region, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 10. Global Human Embryonic Stem Cells market by segment, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 11. Global Human Embryonic Stem Cells market by region, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 12. Global Human Embryonic Stem Cells market by segment, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 13. Global Human Embryonic Stem Cells market by region, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 14. Global Human Embryonic Stem Cells market by segment, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 15. Global Human Embryonic Stem Cells market by region, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 16. U.s. Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 17. U.s. Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 18. Canada Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 19. Canada Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 20. Uk Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 21. Uk Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 22. Germany Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 23. Germany Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 24. Roe Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 25. Roe Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 26. China Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 27. China Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 28. India Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 29. India Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 30. Japan Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 31. Japan Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 32. Roapac Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 33. Roapac Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 34. Brazil Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 35. Brazil Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 36. Mexico Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 37. Mexico Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 38. Rola Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 39. Rola Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 40. Row Human Embryonic Stem Cells market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 41. Row Human Embryonic Stem Cells market estimates & forecasts by segment 2016-2026 (USD Billion)

List of Figures

  • FIG 1. Global Human Embryonic Stem Cells market, research methodology
  • FIG 2. Global Human Embryonic Stem Cells market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Human Embryonic Stem Cells market, key trends 2019
  • FIG 5. Global Human Embryonic Stem Cells market, growth prospects 2020-2026
  • FIG 6. Global Human Embryonic Stem Cells market, porters 5 force model
  • FIG 7. Global Human Embryonic Stem Cells market, pest analysis
  • FIG 8. Global Human Embryonic Stem Cells market, value chain analysis
  • FIG 9. Global Human Embryonic Stem Cells market by segment, 2016 & 2026 (USD Billion)
  • FIG 10. Global Human Embryonic Stem Cells market by segment, 2016 & 2026 (USD Billion)
  • FIG 11. Global Human Embryonic Stem Cells market by segment, 2016 & 2026 (USD Billion)
  • FIG 12. Global Human Embryonic Stem Cells market by segment, 2016 & 2026 (USD Billion)
  • FIG 13. Global Human Embryonic Stem Cells market, regional snapshot 2016 & 2026
  • FIG 14. North America Human Embryonic Stem Cells market 2016 & 2026 (USD Billion)
  • FIG 15. Europe Human Embryonic Stem Cells market 2016 & 2026 (USD Billion)
  • FIG 16. Asia pacific Human Embryonic Stem Cells market 2016 & 2026 (USD Billion)
  • FIG 17. Latin America Human Embryonic Stem Cells market 2016 & 2026 (USD Billion)
  • FIG 18. Global Human Embryonic Stem Cells market, company market share analysis (2019)
目次

Global Human Embryonic Stem Cells Market is valued approximately USD XX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2026. Due to COVID-19 pandemic, the market is facing challenges because of government protocols to stay at home across the world. Human Embryonic Stem Cells (hESCs) are derived from blastocyst and are capable of differentiating into number of cell types that make up the human body as well as it replicates indefinitely and produce non-regenerative tissues such as neural and myocardial cells. They are used in treating a number of blood and genetic disorders related to the immune system, cancers, and disorders as well as used in investigational studies of early human development, genetic diseases and toxicology testing. The technological advancement involving stem cells therapy, rising demand for regenerative medicines, R&D in toxicology testing, technological advancements for the production of embryonic stem cells through alternative methods and increasing prevalence of genetic disorders are the few factors responsible for growth of the market over the forecast period. Furthermore, the introduction of innovative products and other strategic advancements by market players will create lucrative opportunities for the market. For instance, as per company's news release in January 2019, Stemcell Technologies Inc. launched mTeSR™ Plus, an enhanced version of mTeSR™1. mTeSR™ Plus is the stabilized feeder-free maintenance medium for human embryonic stem (ES) and induced pluripotent stem (iPS) cells. However, ethical concern related to stem cell research is the major factor restraining the growth of global Vegetable Chips market during the forecast period.

The regional analysis of global Human Embryonic Stem Cells market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the leading/significant region across the world due to the presence of several prominent entities incorporated in the U.S. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026.

Major market player included in this report are:

Astellas Pharma Inc/ Ocata Therapeutics

Stemcell Technologies Inc.

Biotime, Inc. / Cell Cure Neurosciences LTD

Thermo Fisher Scientific, Inc.

CellGenix GmbH

ESI BIO

PromoCell GmbH

Lonza Group AG

Kite Pharma

Cynata Therapeutics Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

Regenerative Medicine

Stem Cell Biology Research

Tissue Engineering

Toxicology Testing

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017, 2018

Base year - 2019

Forecast period - 2020 to 2026

Target Audience of the Global Human Embryonic Stem Cells Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
    • 1.2.1. Human Embryonic Stem Cells Market, by Region, 2018-2026 (USD Billion)
    • 1.2.2. Human Embryonic Stem Cells Market, by Application, 2018-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Human Embryonic Stem Cells Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Human Embryonic Stem Cells Market Dynamics

  • 3.1. Human Embryonic Stem Cells Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Human Embryonic Stem Cells Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Human Embryonic Stem Cells Market, by Application

  • 5.1. Market Snapshot
  • 5.2. Global Human Embryonic Stem Cells Market by Application, Performance - Potential Analysis
  • 5.3. Global Human Embryonic Stem Cells Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
  • 5.4. Human Embryonic Stem Cells Market, Sub Segment Analysis
    • 5.4.1. Regenerative Medicine
    • 5.4.2. Stem Cell Biology Research
    • 5.4.3. Tissue Engineering
    • 5.4.4. Toxicology Testing

Chapter 6. Global Human Embryonic Stem Cells Market, Regional Analysis

  • 6.1. Human Embryonic Stem Cells Market, Regional Market Snapshot
  • 6.2. North America Human Embryonic Stem Cells Market
    • 6.2.1. U.S. Human Embryonic Stem Cells Market
      • 6.2.1.1. Application breakdown estimates & forecasts, 2016-2026
    • 6.2.2. Canada Human Embryonic Stem Cells Market
  • 6.3. Europe Human Embryonic Stem Cells Market Snapshot
    • 6.3.1. U.K. Human Embryonic Stem Cells Market
    • 6.3.2. Germany Human Embryonic Stem Cells Market
    • 6.3.3. Rest of Europe Human Embryonic Stem Cells Market
  • 6.4. Asia-Pacific Human Embryonic Stem Cells Market Snapshot
    • 6.4.1. China Human Embryonic Stem Cells Market
    • 6.4.2. India Human Embryonic Stem Cells Market
    • 6.4.3. Japan Human Embryonic Stem Cells Market
    • 6.4.4. Rest of Asia Pacific Human Embryonic Stem Cells Market
  • 6.5. Latin America Human Embryonic Stem Cells Market Snapshot
    • 6.5.1. Brazil Human Embryonic Stem Cells Market
    • 6.5.2. Mexico Human Embryonic Stem Cells Market
  • 6.6. Rest of The World Human Embryonic Stem Cells Market

Chapter 7. Competitive Intelligence

  • 7.1. Top Market Strategies
  • 7.2. Company Profiles
    • 7.2.1. Astellas Pharma Inc/ Ocata Therapeutics
      • 7.2.1.1. Key Information
      • 7.2.1.2. Overview
      • 7.2.1.3. Financial (Subject to Data Availability)
      • 7.2.1.4. Product Summary
      • 7.2.1.5. Recent Developments
    • 7.2.2. Stemcell Technologies Inc.
    • 7.2.3. Biotime, Inc. / Cell Cure Neurosciences LTD
    • 7.2.4. Thermo Fisher Scientific, Inc.
    • 7.2.5. CellGenix GmbH
    • 7.2.6. ESI BIO
    • 7.2.7. PromoCell GmbH
    • 7.2.8. Lonza Group AG
    • 7.2.9. Kite Pharma
    • 7.2.10. Cynata Therapeutics Ltd

Chapter 8. Research Process

  • 8.1. Research Process
    • 8.1.1. Data Mining
    • 8.1.2. Analysis
    • 8.1.3. Market Estimation
    • 8.1.4. Validation
    • 8.1.5. Publishing
  • 8.2. Research Attributes
  • 8.3. Research Assumption